| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | WIPO (World Intellectual Property Organization) | 6 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | Brazil | 2 | |
| #5 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Computer technology | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Measuring microorganism processes | |
| #5 | Microorganisms | |
| #6 | Analysing materials | |
| #7 | Bioinformatics | |
| #8 | Electric digital data processing |
| # | Name | Total Patents |
|---|---|---|
| #1 | Howard Tommy E | 9 |
| #2 | Howard Tommy Eugene | 5 |
| #3 | La Terza Vincent | 5 |
| #4 | Laterza Vincent | 4 |
| #5 | Howard Thomas E | 2 |
| #6 | Howard Tom E | 1 |
| #7 | Tommy Eugene Howard | 1 |
| #8 | Tommy E Howard | 1 |
| #9 | Bennett David | 1 |
| #10 | Vincent Laterza | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2017112895A1 | F8 gene repair | |
| US2015216944A1 | Allelic variants of human factor viii | |
| WO2015054439A2 | Hybrid factor viii polypeptides for use to treat hemophilia a | |
| WO2014145524A2 | Compositions and methods for immune tolerance induction to factor viii replacement therapies in subjects with hemophilia a | |
| WO2014089541A2 | Factor viii mutation repair and tolerance induction | |
| BR112012017483A2 | prediction and reduction of alloimmunogenicity of protein therapeutics | |
| WO2011046568A1 | Compositions and methods of treatment of black hemophiliac patients |